Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A known ✓ | Q03164 | 2/20 | 0.46 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.47 |
| ▸ | HTR1F | P30939 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CCR3 | P51677 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PTGIR | P43119 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL8716648 | 1.00 | HSD11B1 (0.47) | HSD11B1MEN1KMT2AHTR1FNPSR1 | |
| SCHEMBL8710891 | 0.96 | HSD11B1 (0.51) | HSD11B1MEN1KMT2AHTR1FNPSR1 | |
| Fumaric Acid SCHEMBL8710683 | 0.94 | HSD11B1 (0.47) | HSD11B1MEN1KMT2ALMNASMN1; SMN2 | |
| Maleic Acid SCHEMBL8710680 | 0.94 | HSD11B1 (0.47) | HSD11B1MEN1KMT2ALMNASMN1; SMN2 | |
| Fumaric Acid SCHEMBL8711294 | 0.94 | HSD11B1 (0.47) | HSD11B1MEN1KMT2ALMNASMN1; SMN2 | |
| Fumaric Acid SCHEMBL9233869 | 0.92 | MEN1 (0.51) | HSD11B1MEN1KMT2AHTR1FLMNA | |
| Fumaric Acid SCHEMBL9233858 | 0.92 | MEN1 (0.51) | HSD11B1MEN1KMT2AHTR1FLMNA | |
| Fumaric Acid SCHEMBL8712491 | 0.91 | MEN1 (0.51) | MEN1KMT2AHTR1FLMNASMN1; SMN2 | |
| Fumaric Acid SCHEMBL8712490 | 0.91 | MEN1 (0.51) | MEN1KMT2AHTR1FLMNASMN1; SMN2 | |
| Fumaric Acid SCHEMBL8712287 | 0.90 | HSD11B1 (0.46) | HSD11B1MEN1KMT2ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5728835-A | HYPOTENSIVE AGENTS; ANTIISCHEMIC AGENTS | TOA EIYO, LTD. (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0661266-A1 | Substituted cyclic amine compounds as 5HT2 antagonists | TOA EIYO LTD. (JP) | 1995-07-05 | — | — | EP | disclosed |